Nephroplus is a company based in Hyderabad, Telangana, India, operating in the healthtech sector. Founded in 2009, it now employs 1147 individuals. The company was established by Kamal D Shah, Sandeep...
Nephroplus: Financial Breakdown
Decoding The Financial Health & Metrics Of Nephroplus
Total Revenue
-3%
Prev FY
₹45.1 Cr
Total Expenses
-38%
Prev FY
₹40.4 Cr
Profit After Tax
126%
Prev FY
₹4.7 Cr
Total Assets
3%
Prev FY
₹45.5 Cr
Net Profit Margin
127%
Prev FY
0.1%
Note: Above mentioned stats are for FY 2019-2020
Nephroplus: Profit and loss Highlights
Total Revenue
-3%
Prev FY
₹45.1 Cr
Total Expenses
-38%
Prev FY
₹40.4 Cr
Profit Before Tax
126%
Prev FY
₹4.7 Cr
Profit After Tax
126%
Prev FY
₹4.7 Cr
Note: Above mentioned stats are for FY 2019-2020
Over Years
Nephroplus Profit & loss statement
Financial Year
Trend
2018
2019
2020
Revenue from Operations (₹)
40.4 Cr
46.3 Cr
44.7 Cr
Other Income (₹)
55.0 Lakh
15.0 Lakh
39.0 Lakh
Total Revenue (₹)
41.0 Cr
46.4 Cr
45.1 Cr
EXPENSES
Cost of Materials Consumed (₹)
12.5 Cr
11.9 Cr
11.2 Cr
Purchases of Stock in Trade (₹)
0.0
0.0
0.0
Changes in Inventory (₹)
-1.2 Cr
1.1 Cr
-9.0 Lakh
Employee Benefit Expenses (₹)
18.1 Cr
18.3 Cr
7.4 Cr
Finance Costs (₹)
0.0
0.0
0.0
Depreciation and Amortization (₹)
6.4 Cr
5.7 Cr
4.4 Cr
Other Expenses (₹)
26.6 Cr
27.2 Cr
17.5 Cr
Total Expenses (₹)
62.5 Cr
64.2 Cr
40.4 Cr
Total Revenue Less Total Expenses (₹)
-21.5 Cr
-17.7 Cr
4.7 Cr
Prior Period and Exceptional Items (₹)
0.0
0.0
0.0
Profit Before Tax (₹)
-21.5 Cr
-17.7 Cr
4.7 Cr
TAX EXPENSES
Current Tax Expense (₹)
0.0
0.0
0.0
Deferred Tax Expense (₹)
0.0
0.0
0.0
Total Tax Expense (₹)
0.0
0.0
0.0
Net Movement in Regulatory Deferral Account Balances (₹)
0.0
0.0
0.0
Profit from Continuing Operations (₹)
-21.5 Cr
-17.7 Cr
4.7 Cr
Profit from Discontinuing Operations After Tax (₹)
0.0
0.0
0.0
Net Profit/Loss After Tax (₹)
-21.5 Cr
-17.7 Cr
4.7 Cr
Other Comprehensive Income (₹)
0.0
0.0
0.0
Total Comprehensive Income (₹)
0.0
0.0
0.0
Profit Before Extraordinary Items (₹)
-21.5 Cr
-17.7 Cr
4.7 Cr
Extraordinary Items (₹)
0.0
0.0
0.0
Unlock all exclusive financials data
When you create a free Inc42 account, you unlock unlimited access to all search results, companies, investors, funding and much more.
Nephroplus generated a total revenue of ₹40.4 Cr and incurred expenses of ₹40.4 Cr, resulting in a profit before tax of ₹4.7 Cr for FY 2019-2020. After a total tax expense of ₹0.0, the profit after tax stood at ₹4.7 Cr.
Nephroplus: Balance Sheet
Balance Sheet highlights of Nephroplus and a snapshot of its key metrics.
Equity Share Capital
₹21.9 Cr
Non Current Liability
-25%
Prev FY
₹48.0 Lakh
Current Liability
-32%
Prev FY
₹6.3 Cr
Total Liability
-32%
Prev FY
₹6.8 Cr
Non Current Assets
-6%
Prev FY
₹25.8 Cr
Current Assets
18%
Prev FY
₹19.7 Cr
Note: Above mentioned stats are for FY 2019-2020
Over Years
Nephroplus Balance Sheet Table
Financial Year
Trend
2018
2019
2020
EQUITY & LIABILITIES
Equity Share Capital (₹)
19.5 Cr
21.9 Cr
21.9 Cr
Reserves & Surplus (₹)
16.2 Cr
12.1 Cr
16.8 Cr
Money Received Against Share Warrants (₹)
0.0
0.0
0.0
Money Pending Allotment (₹)
0.0
0.0
0.0
Other Equity (₹)
0.0
0.0
0.0
NON-CURRENT LIABILITIES
FINANCIAL LIABILITIES
Borrowings (₹)
0.0
0.0
0.0
Trade Payables (₹)
0.0
0.0
0.0
Other Financial Liabilities (₹)
0.0
0.0
0.0
Provisions (₹)
39.0 Lakh
35.0 Lakh
18.0 Lakh
Deferred Tax Liabilities (Net) (₹)
0.0
0.0
0.0
Other Liabilities (₹)
37.0 Lakh
29.0 Lakh
30.0 Lakh
Total Non-current Liabilities (₹)
76.0 Lakh
64.0 Lakh
48.0 Lakh
CURRENT LIABILITIES
FINANCIAL LIABILITIES
Borrowings (₹)
0.0
0.0
0.0
Trade Payables (₹)
4.1 Cr
4.7 Cr
4.3 Cr
Other Financial Liabilities (₹)
0.0
0.0
0.0
Provisions (₹)
29.0 Lakh
16.0 Lakh
9.0 Lakh
Current Tax Liabilities (Net) (₹)
0.0
0.0
0.0
Other Liabilities (₹)
4.9 Cr
4.5 Cr
1.9 Cr
Total Current Liabilities (₹)
9.3 Cr
9.3 Cr
6.3 Cr
Liabilities Associated with Assets in Disposal Group (₹)
0.0
0.0
0.0
Regulatory Deferral Account Credit Balances (₹)
0.0
0.0
0.0
Total Equity and Liabilities (₹)
45.8 Cr
44.0 Cr
45.5 Cr
ASSETS
NON-CURRENT ASSETS
Property Plant and Equipment (₹)
0.0
0.0
0.0
Capital Work in Progress (₹)
51.0 Lakh
0.0
0.0
Investment Property (₹)
0.0
0.0
0.0
Goodwill (₹)
0.0
0.0
0.0
Intangible Assets (₹)
3.6 Cr
3.1 Cr
2.6 Cr
Intangible Assets under Development (₹)
0.0
0.0
0.0
FINANCIAL ASSETS
Investments (₹)
0.0
0.0
0.0
Trade Receivables (₹)
0.0
0.0
0.0
Loans (₹)
5.1 Cr
7.0 Cr
7.0 Cr
Other Financial Assets (₹)
0.0
1.0 Lakh
1.0 Cr
Deferred Tax Assets (Net) (₹)
0.0
0.0
0.0
Other Assets (₹)
0.0
0.0
0.0
Tangible Assets (₹)
21.6 Cr
17.3 Cr
15.1 Cr
Total Non-current Assets (₹)
30.8 Cr
27.4 Cr
25.8 Cr
CURRENT ASSETS
Inventories (₹)
2.5 Cr
1.4 Cr
1.4 Cr
FINANCIAL ASSETS
Investments (₹)
0.0
0.0
0.0
Trade Receivables (₹)
8.9 Cr
9.0 Cr
9.6 Cr
Cash and Cash Equivalents (₹)
1.2 Cr
5.0 Cr
7.6 Cr
Other Bank Balances with Banks (₹)
0.0
0.0
0.0
Loans (₹)
2.3 Cr
1.3 Cr
1.0 Cr
Other Financial Assets (₹)
0.0
0.0
0.0
Current Tax Assets (₹)
0.0
0.0
0.0
Other Assets (₹)
9.0 Lakh
0.0
9.0 Lakh
Total Current Assets (₹)
15.0 Cr
16.6 Cr
19.7 Cr
NON-CURRENT ASSETS HELD FOR SALE (₹)
0.0
0.0
0.0
REGULATORY DEFERRAL ACCOUNT DEBIT BALANCES (₹)
0.0
0.0
0.0
TOTAL ASSETS (₹)
45.8 Cr
44.0 Cr
45.5 Cr
Unlock all exclusive financials data
When you create a free Inc42 account, you unlock unlimited access to all search results, companies, investors, funding and much more.
As of FY 2019-2020, Nephroplus has an equity share capital of ₹21.9 Cr, total assets amounting to ₹45.5 Cr, and total liabilities of ₹6.8 Cr.
Nephroplus: Cash Flow
Cash Flow highlights of Nephroplus and a snapshot of its key metrics.
Cash Balance (Beginning of year)
315%
Prev FY
₹5.0 Cr
Cash Flow (Operating Activities)
137%
Prev FY
₹4.1 Cr
Cash Used (Investing Activities)
-422%
Prev FY
₹-7.7 Cr
Note: Above mentioned stats are for FY 2019-2020
Nephroplus Cash Flow Table
Financial Year
Trend
2018
2019
2020
CASH AND EQUIVALENTS AT THE BEGINNING
Cash flows from / used in investing activities (₹)
-8.5 Cr
-1.5 Cr
-7.7 Cr
Cash flows from / used in financing activities (₹)
10.0 Cr
16.0 Cr
0.0
Adjustments for exchange rate changes (₹)
0.0
0.0
0.0
Unlock all exclusive financials data
When you create a free Inc42 account, you unlock unlimited access to all search results, companies, investors, funding and much more.
For FY 2019-2020, Nephroplus maintained a cash balance of ₹5.0 Cr, with cash flows from operations at ₹4.1 Cr, investing activities at ₹-7.7 Cr, and financing activities at ₹0.0.
Nephroplus: Financial Ratio
Financial Ratio highlights of Nephroplus and a snapshot of its key metrics.
Earning Per Share
123%
Prev FY
₹0.1
Net Profit Margin
127%
Prev FY
0.1%
Return on Assets
130%
Prev FY
₹0.3
Debt/Equity
-58%
Prev FY
0.1
Current Ratio
74%
Prev FY
3.1
Note: Above mentioned stats are for FY 2019-2020
Nephroplus Financial Ratios Table
Financial Year
Trend
2018
2019
2020
Total Debt/Equity Ratio (X)
0.1
0.1
0.1
Total Debt/Total Assets Ratio (X)
0.1
0.1
0.1
Total Assets/Equity Ratio (X)
1.3
1.3
1.2
Net Debt/Equity Ratio (X)
0.1
-0.0
-0.1
Quick Ratio (X)
1.1
1.5
2.7
Current Ratio (X)
1.6
1.8
3.1
Interest Coverage Ratio (X)
0.0
0.0
0.0
Gross Margin (%)
0.7
0.7
0.8
Net Margin (%)
-0.5
-0.4
0.1
EBITDA Margin (%)
-0.4
-0.3
0.2
Return on Fixed Assets (₹)
-0.8
-0.9
0.3
Return on Equity (X)
-0.6
-0.5
0.1
Return on Capital Employed (X)
-0.7
-0.6
0.1
Fixed Asset Turnover (₹)
1.6
2.3
2.5
Days Receivables Outstanding
80.0
70.0
78.0
Days Payables Outstanding
39.0
42.0
55.0
Days of Inventory
79.0
38.0
47.0
Enterprise Value (₹)
0.0
0.0
0.0
Unlock all exclusive financials data
When you create a free Inc42 account, you unlock unlimited access to all search results, companies, investors, funding and much more.
In FY 2019-2020, Nephroplus achieved a net profit margin of 0.10, earnings per share of ₹0.12, a debt/equity ratio of 0.06, and a current ratio of 3.10.
FAQs On Financial Health Of Nephroplus
What were Nephroplus's total revenue and profit for the latest financial year?
For FY 2019-2020, Nephroplus reported a total revenue of ₹45.1 Cr and a profit after tax of ₹4.7 Cr, showcasing its financial performance and profitability.
How does the balance sheet of Nephroplus reflect its financial stability?
As of FY 2019-2020, Nephroplus has total assets of ₹45.5 Cr, total liabilities of ₹6.8 Cr, and equity share capital of ₹21.9 Cr, indicating its financial health and stability.
What insights can be gained from Nephroplus's cash flow management?
In FY 2019-2020, Nephroplus maintained a cash balance of ₹5.0 Cr, with cashflows from operations at ₹4.1 Cr, investing activities at ₹-7.7 Cr, and financing activities at ₹0.0, reflecting its cash management strategies.
What do the key financial ratios of Nephroplus indicate?
For FY 2019-2020,Nephroplus achieved a net profit margin of 0.10%, earning per share of ₹0.1, and a debt/equity ratio of 0.1, and a current ratio of 3.1, offering insights into its profitability, leverage, and liquidity.
How has Nephroplus's financial performance evolved compared to previous year?
Compared to the previous year, Nephroplus experienced a -2.91% decrease in total revenue and a 126.27% decrease in profit after tax, highlighting its growth and change in profitability.
Explore More With A Free Inc42 Account
Enjoy unlimited access to comprehensive data on companies, investors, funding, finances, investments, acquisitions, and much more.
-- Already Have An Account? --
Discover Your Edge With
Inc42 Datalabs
Whether you're an entrepreneur, investor, corporate innovator or consultant, Datalabs empowers you with the insights you need to stay ahead of the game.
Company & Investor Data
Gain access to India's most extensive database of startups, scaleups, and investors, complete with verified.
Company & Investor Data
Gain access to India's most extensive database of startups, scaleups, and investors, complete with verified.
Industry & Location Insights
Gain access to India's most extensive database of startups, scaleups, and investors, complete with verified.
Industry & Location Insights
Gain access to India's most extensive database of startups, scaleups, and investors, complete with verified.
Track Customers &Competitors
Gain access to India's most extensive database of startups, scaleups, and investors, complete with verified.
Track Customers &Competitors
Gain access to India's most extensive database of startups, scaleups, and investors, complete with verified.
In-Depth Research Reports
Gain access to India's most extensive database of startups, scaleups, and investors, complete with verified.
In-Depth Research Reports
Gain access to India's most extensive database of startups, scaleups, and investors, complete with verified.
India's Most Comprehensive
Startup Database
Gain access to India's most extensive database of startups, scaleups, and investors, complete with verified information, funding & more.
Market Research and Competitive Intelligence
Conduct comprehensive research and analysis with access to a vast dataset, including similar companies, deals, funding rounds, and exits.
Identify New Prospects
Qualify Leads Efficiently
Timely Engagement with Leads
Market Research and Competitive Intelligence
Conduct comprehensive research and analysis with access to a vast dataset, including similar companies, deals, funding rounds, and exits.
Identify New Prospects
Qualify Leads Efficiently
Timely Engagement with Leads
Deal Sourcing and Investment Analysis
Conduct comprehensive research and analysis with access to a vast dataset, including similar companies, deals, funding rounds, and exits.
In-Depth Company and Industry Analysis
Discover Industry Trends and Insights
Explore Industry Landscapes
Sales and Marketing Intelligence
Conduct comprehensive research and analysis with access to a vast dataset, including similar companies, deals, funding rounds, and exits.
Welcome aboard! You've just completed your onboarding to Inc42 DataLabs. Now, a world of unparalleled insights is at your fingertips. Dive in, discover, and let the adventure begin. Happy exploring!
Set Email Alerts on preferred industry
Set Email Alerts on preferred industry
Your Selected Companies Has Been Added To Your List
Your Selected Companies Has Been Added To A New List